Joachim R. Kalden

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair et al. · New England Journal of Medicine · 2000 · 3K citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus

Martin Herrmann, Reinhard Voll, Otmar Zoller et al. · Arthritis & Rheumatism · 1998 · 832 citations

Life Sciences, Immunology, Pathology +16

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

Kirsten Neubert, Silke Meister, Katrin Moser et al. · Nature Medicine · 2008 · 576 citations

Medicine, Immunology, Pharmacology +16

Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus

Irith Baumann, Wasilis Kolowos, Reinhard Voll et al. · Arthritis & Rheumatism · 2002 · 557 citations

Medicine, Immunology, Pathology +17